Page last updated: 2024-10-17

aminocaproic acid and Bernard-Soulier Syndrome

aminocaproic acid has been researched along with Bernard-Soulier Syndrome in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Bernard-Soulier Syndrome: A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozelo, MC1
Svirin, P1
Larina, L1
Peng, TC1
Kickler, TS1
Bell, WR1
Haller, E1

Other Studies

2 other studies available for aminocaproic acid and Bernard-Soulier Syndrome

ArticleYear
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Annals of hematology, 2005, Volume: 84, Issue:12

    Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Bernard-Soulier Syndrome; Epistaxis;

2005
Obstetric complications in a patient with Bernard-Soulier syndrome.
    American journal of obstetrics and gynecology, 1991, Volume: 165, Issue:2

    Topics: Adult; Aminocaproic Acid; Bernard-Soulier Syndrome; Female; gamma-Globulins; Humans; Immunity, Mater

1991